Bluefin Capital Management, LLC Seagen Inc. Put Options Transaction History

Bluefin Capital Management, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $516 Million - $583 Million	2,696,300 Added 97.12%	5,472,500 $1.16 Billion
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $498 Million - $548 Million	2,656,100 Added 2211.57%	2,776,200 $534 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $15.3 Million - $24.4 Million	120,100 New	120,100 $24.3 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Bluefin Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bluefin Capital Management, LLC with notifications on news.